This chapter focuses on structure and expression of interleukin-6 (IL-6), which is a cytokine with pleiotropic activities that plays a central role in host defense. IL-6 can exert growth-inducing, growth-inhibitory, and differentiation-inducing activities, depending on the target cells. These activities include (1) terminal differentiation (secretion of immunoglobulins) in B cells and (2) growth promotion on various B cells. IL-6 has been implicated in the pathology of many diseases including multiple myeloma, mesangial proliferative glomerulonephritis, rheumatoid arthritis, and acquired immunodeficiency syndrome (AIDS). Selective inhibition of the synthesis or of the action of IL-6 may have therapeutic benefit against the IL-6-associated diseases. On the other hand, IL-6 has potent antitumor activity against certain types of tumors. Application of IL-6 is promising in cancer treatment as well as in treatment of radiation- or chemotherapy-induced myelosuppression. The cell biology of the intracellular events that link transduction to gene regulation is an important area, and work on these topics helps to understand such phenomena as multifunction of IL-6 and bidirectional effects of cell growth depending on the cell type.
Carla Zoja, Jiming Wang, S Bettoni, Marina Sironi, Daniela Renzi, Francesça Chiaffarino, Hanna E. Abboud, Jo Van Damme, Alberto Mantovani, Giuseppe Remuzzi
Julia Lichtnekert, Volker Vielhauer, Daniel Zecher, Onkar P. Kulkarni, Sebastian Clauß, Stephan Segerer, Veit Hornung, Tanya N. Mayadas, Bruce Beutler, Akira Shizuo, Hans‐Joachim Anders
Discussion(0)
No comments yet. Be the first to comment.